psilocybin attunement: therapeutic microdosing for mental health

Yes, I offer virtual support for people nationwide, helping you understand microdosing safety, harm reduction and ethical practices. It’s important to note psilocybin is federally illegal and only legalized, de-prioritized or decriminalized in certain areas. It is up to each individual person to know their local laws and regulations and make their own sovereign choices when it comes to microdosing psilocybin.

No prescription is required. Psilocybin is not an FDA-approved prescription medication. Enrollment in microdosing support or therapeutic microdosing programs require completing an intake questionnaire and an individual screening call with the facilitator to confirm fit and safety.

No. Some clients come to me already doing other therapeutic work and want microdosing support layered on top. Others start here first. I operate in a coaching framework without the need for a psychiatric diagnosis, making microdosing accessible to most people. We’ll figure out what makes sense for you in your free consultation.

If you’re curious about building a safe, structured, supported relationship with psilocybin microdosing – rather than approaching it alone through trial and error – the next step is scheduling a screening call. That conversation is designed to help you and the facilitator determine together whether this program is the right fit and timing for you.

SSRIs work through continuous, daily serotonin reuptake inhibition, with effects building gradually over weeks of steady use. Microdosing psilocybin works differently: it’s taken intermittently (not daily), and appears to support neuroplasticity; the brain’s capacity to form new neural connections, through direct, acute interaction with serotonin 5-HT2A receptors rather than a sustained neurochemical shift. Many people also describe the felt experience differently: SSRIs are sometimes described as blunting emotion, while microdosing is more often described as increasing emotional access and a sense of reconnection, rather than numbing. Microdosing is not a prescribed medication and does not carry the same dependency or discontinuation profile as SSRIs, since it isn’t taken daily.

This varies person to person, and I won’t give you a false promise of a specific timeline. What I can tell you is that microdosing is a practice, not a single event. The benefits tend to build with consistency and with the support around it, not from any one dose. I recommend starting with a 90 day protocol and building a solid foundation, giving yourself plenty of time to see long term effects from your focused practice.

Not automatically. t=This is exactly why the process starts with a free consultation and pre-screening. Certain medications, mental health histories, and medical conditions may be points of contraindication or consideration, and part of my job is helping you figure out honestly whether this is a fit before you begin.

That’s exactly how I built this work to flow. Microdosing, medium dosing, and high-dose journeys aren’t separate paths. They’re part of one continuum, and we can move along it together as it makes sense for you.

That’s completely fine. Many of my clients are entering this work for the first time. Starting with microdosing, rather than a full journey, is actually one of the gentler ways to begin.

The Fadiman protocol, developed by researcher Dr. James Fadiman, is one of the most widely referenced microdosing schedules: a dosing day followed by two rest days, repeated in a cycle. It’s used in the Therapeutic Microdosing program as a well-studied, conservative starting structure – most participants begin with a Fadiman-based protocol in Week 2 and, later in the program, learn to adjust toward a more personalized, intuitive rhythm as they build experience.

Therapeutic microdosing is a structured, professionally facilitated approach to microdosing psilocybin; built around clinical screening, a defined protocol, ongoing support, and integration work, rather than starting on your own and figuring it out as you go. Self-guided microdosing is what most people do by default: sourcing information from forums, podcasts, or books, and adjusting dose and schedule through personal trial and error, without professional oversight.

The differences that matter most in practice:

• Screening for contraindications. A therapeutic program includes an individual screening call to rule out factors that make microdosing unsafe for a given person – personal or family history of psychosis or bipolar disorder, certain medication interactions, pregnancy, and cardiovascular concerns, among others. Self-guided microdosing has no equivalent safety check; the person doing it is the only one evaluating whether it’s appropriate for them.
• A structured, evidence-informed protocol. Rather than guessing at dose and schedule, a therapeutic program uses a defined starting protocol (such as the Fadiman method) and teaches participants how to read their own data and adjust responsibly over time.
• Ongoing support and troubleshooting. If something feels off, isn’t working, or brings up more than expected, there’s a licensed facilitator to bring it to – not just an online forum or personal guesswork.
• Deliberate integration. Therapeutic microdosing treats the practice as one part of a larger mind-body-spirit process – pairing the dosing itself with intentional work around mental health psychoeducation, nervous system support, relationship, nature connection, and meaning-making. Self-guided microdosing typically has no built-in integration structure at all.
• Tracking and measurable outcomes. A therapeutic program uses structured tracking and pre/post assessments, so a participant (and their facilitator) can actually see what changed over time, rather than relying on vague impressions.
• Community or individualized clinical attention. Whether in a group or one-on-one container, therapeutic microdosing offers a relationship with a trained facilitator throughout the process – something entirely absent from doing this alone.

In short: self-guided microdosing is something a person does to themselves, on their own; therapeutic microdosing is something a person does with professional support, safety infrastructure, and a container built around sustained change.

A macrodose journey is a single, immersive experience – a full day, an altered state, a lot of surrender in one sitting. Microdosing is the opposite approach: small, sub-perceptual amounts taken on a regular schedule, worked into your normal life rather than set apart from it. Neither one is “more legitimate” than the other – they’re different tools for different needs, and some people benefit from both at different points in their process.